NCT06473896View on ClinicalTrials.gov

Effect of Ketalar or Dexmedetomidine on Increased Sensitivity to Pain Following Treatment With Remifentanil

NARecruitingINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

April 18, 2024

Primary Completion Date

April 30, 2026

Study Completion Date

August 30, 2026

Conditions
Cholecystectomy
Interventions
DRUG

Ketalar

a dissociative anesthetic used medically for induction and maintenance of anesthesia

DRUG

Dexmedetomidine

an agonist of α2-adrenergic receptors in certain parts of the brain used for sedation

Trial Locations (1)

70300

RECRUITING

Shamir (Asaf Harofe) Medical Center, Be’er Ya‘aqov

All Listed Sponsors
lead

Assaf-Harofeh Medical Center

OTHER_GOV